Press release
Global Surge In Cancer Cases And Its Effect On The Market Driver: Leading Transformation in the Immuno-Oncology Drugs Market in 2025
Immuno-Oncology Drugs
The global ascend in cancer cases is forecasted to propel the growth of the immuno-oncology drugs market. In recent data from January 2022 provided by the American Cancer Society, it is predicted that there will be approximately 1.9 million new cancer detections and 609,360 deaths linked to cancer in the United States, equating to around 1,670 casualties each day. Around the globe, lung, prostate, bowel, and female breast cancer are the four predominantly found types of cancer, responsible for 43% of all newly diagnosed cancer cases. As a result, the surge in worldwide cancer prevalence rates is expected to drive increased demand for immuno-oncology medicines over the forthcoming years.
Get Your Immuno-Oncology Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report
What is the projected compound annual growth rate (CAGR) of the immuno-oncology drugs market from 2025 to 2034, and what factors influence it?
The market size for immuno-oncology drugs has seen a swift expansion in the recent past. Predictions suggest an increase from $94.16 billion in 2024 to $106.92 billion in 2025, projecting a compound annual growth rate (CAGR) of 13.6%. Factors contributing to this historical growth include a surge in cancer incidences, robust financial development in emerging markets, escalated spending in healthcare, and a rise in R&D investments in the pharmaceutical sector.
The market for immuno-oncology drugs is anticipated to exhibit robust growth in the forthcoming years, expanding to a value of $153.16 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.4%. This predicted growth during the forecast period is likely due to the accelerating investment in immuno-oncology, the heightened emphasis on immunotherapy drugs for cancer treatments, and product advancements. Key trends expected during this period include investing in the creation of personalized oncology drugs for targeted patients, focusing on the production of next-generation biologics, devoting efforts to the formulation of antibody-drug conjugates, injecting funds into Artificial Intelligence solutions, cutting back on R&D costs and shortening development time, exploiting immuno-oncology combination therapies to spur innovation and anchor category leadership, and employing car-t therapies to further boost innovation and fortify category leadership.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3455&type=smp
What new trends are reshaping the immuno-oncology drugs market and its opportunities?
Leading firms in the immuno-oncology drugs sector are partnering to innovate and market a ground-breaking checkpoint antibody to augment cancer therapy effectiveness. Such strategic alliances stimulate novelty by promoting an interchange of expertise across various disciplines, thereby accelerating the progress of combined therapies, customised treatments and innovative drug delivery systems. For example, in March 2023, BioNTech SE, originating from Germany, collaborated with OncoC4 Inc from the US, to jointly innovate and market a checkpoint antibody, specifically the anti-CTLA-4 monoclonal antibody referred to as ONC-392. The aim of this collaboration is to enhance the variety of treatments for cancer across numerous solid tumor types.
What are the major segments of the immuno-oncology drugs market and their role in driving growth?
The immuno-oncology drugs market covered in this report is segmented -
1) By Type: Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others
2) By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application
3) By End-Users: Hospitals, Clinics, Ambulatory Surgical Centers, Others
Subsegments:
1) By Immune Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
2) By Immune System Modulators: Cytokines, Interferons, Colony-Stimulating Factors
3) By Other Monoclonal Antibodies: Targeted Monoclonal Antibodies, Bispecific Antibodies
4) By Cancer Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
5) By Others: Adoptive Cell Transfer Therapies, Oncolytic Virus Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3455
Which regions are key players in the growth of the immuno-oncology drugs market?
North America was the largest region in the immuno-oncology drugs market in 2024. The regions covered in the immuno-oncology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the key firms paving the way for growth in the immuno-oncology drugs market?
Major companies operating in the immuno-oncology drugs market include F. Hoffmann-La Roche Ltd., Merck & Co., Bristol-Myers Squibb Company, Amgen Inc, Johnson & Johnson, AstraZeneca Plc, Eli Lilly and Company, Novartis International AG, Pfizer Inc., Sanofi S.A., Arlak Biotech, Apikos Pharma, Kolaz biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc, Otsuka Pharmaceutical Co, Ltd, Legend Biotech Co, Zai Lab, Daiichi Pharmaceutical and Sankyo, AQVIDA GmbH, Baxter International Inc., GlaxoSmithKline plc, Affimed Therapeutics, Autolus Therapeutics, Cellectis, Celyad, GammaDelta Therapeutics, Immunocore, European Medical Center (EMC), Yauza Medical Center, Celon Pharma, Veropharm, Biocad, Selvita, OncoArendi Therapeutics Mabion, Fate Therapeutics, Forty-Seven, Arcus Biosciences, Gritstone Oncology, Rakuten Medical, Rubius Therapeutics, Allogene Therapeutics, Celgene Corporation, Bayer AG, Incyte Corporation, Recepta Biopharma, CSC Pharmaceuticals International, Blanver EN, Sandoz Brazil, Life Pharma, Julphar, NewBridge Pharmaceuticals, Eurolab
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3455&type=smp
What Is Covered In The Immuno-Oncology Drugs Global Market Report?
• Market Size Forecast: Examine the immuno-oncology drugs market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the immuno-oncology drugs market for a structured understanding.
• Key Players Overview: Analyze major players in the immuno-oncology drugs market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the immuno-oncology drugs market.
• Segment Contributions: Evaluate how different segments drive overall growth in the immuno-oncology drugs market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the immuno-oncology drugs market.
• Industry Challenges: Identify potential risks and obstacles affecting the immuno-oncology drugs market.
• Competitive Landscape: Review strategic developments in the immuno-oncology drugs market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Surge In Cancer Cases And Its Effect On The Market Driver: Leading Transformation in the Immuno-Oncology Drugs Market in 2025 here
News-ID: 3904039 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Therapeutic
Exosome Therapeutic Market : Detailed Overview
Introduction:
The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,…
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),…
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028.
Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market.
Browse 147 Market Data Tables and 115…
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers…
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies…
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
